Pfizer’s drug to treat rare haemophilia disorder gets US regulator’s approval
Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder.
Drugs
Health
Pharma
Drugs
Health
Pharma
Sage Therapeutics halts trials of experimental drug to treat dementia
Sage Therapeutics Inc.’s experimental drug failed to meet its main goal of treating mild dementia due to Alzheimer's disease and the US, Cambridge-headquartered.
Drugs
Health
Medical
J&J stops trials on drug to treat muscle-invasive bladder cancer
Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results
Drugs
Health
Pharma
Gilead signs six global pacts to make, sell generic HIV preventive drug
Gilead Sciences, Inc. has signed non-exclusive, royalty-free voluntary licensing agreements with six pharmaceutical makers to make and sell its generic lenacapavir drug for the prevention.
Drugs
Health
Medical
Lilly to invest $4.5 billion to build Medicine Foundry in Indiana state, US
Eli Lilly and Company will build a $4.5 billion center for advanced manufacturing and drug development in Indiana to innovate new production methods.
Drugs
Health
Pharma
Amplifica’s human trial medicine for hair growth shows 15% more efficacy
Amplifica Holdings Group Inc.’s first-in-human trial of an injectable medicine for treating hair loss has shown a more than 15% increase in non-vellus.
Drugs
Health
Pharma
Merck’s trial drug combination for colorectal cancer fails main goal
Merck & Co., announced its trial drug along with a combination of the company’s Keytruda therapy failed to meet the main goal of.
Drugs
Health
Pharma
Amgen’s trial drug to fight autoimmune disorder improves patient outcomes
Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial.
Drugs
Health
Pharma
AstraZeneca-Daiichi Sankyo’s breast cancer drug fails in late-stage trial
British-Swedish AstraZeneca and Japan's Daiichi Sankyo’s investigational drug for breast cancer failed to significantly improve the overall survival of the patients during an.
Drugs
Health
Pharma
Novo’s Wegovy gets EMA nod to treat heart failure in obese people
Denmark’s Novo Nordisk got the backing of the European Medicines Agency for its Wegovy drug to reduce heart failure in obese people.